Managers

Translink Capital rakes in $107.5 mln for fourth fund

Translink Capital Partners has raised $107.5 million for its fourth fund, according to an SEC filing. No target was listed on the document. The Palo Alto, California-based venture firm "helps entrepreneurs develop customer connections and partnerships in Asia."

Carmot Therapeutics scores $15 mln

Berkeley, California-based Carmot Therapeutics Inc, a biotech company, has secured $15 million in financing. Horizons Ventures and The Column Group led the round. In addition to the funding, Patrick Zhang of Horizons Ventures has become a board observer while Dr. Adriana Tajonar from The Column Group was added to the board of directors.

Pandion Therapeutics snags $58 mln Series A

Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company, has closed $58 million in Series A financing. Polaris Partners, Versant Ventures and Roche Venture Fund led the round with participation from SR One and BioInnovation Capital.

Ring Capital raises over 140 mln euros for venture fund

Ring Capital, a Paris-based venture firm, has raised over 140 million euros. The fund's backers include Tikehau Capital, AG2R La Mondiale, BPI France, Bred and Danone. The fund will focus on European growth-stage tech companies. Also, Tikehau has acquired a 25 percent stake in Ring Capital.

InvestX rolls out growth fund that accepts digital currency

InvestX Master GP1 has launched a growth equity fund that will accept both traditional and digital currency. The minimum fundraising target is $20 million with a hard cap at $100 million. InvestX Global Growth Equity Fund will be available to accredited investors in Canada, the United States and internationally. Vancouver-based InvestX provides accredited investors, family offices, and institutional investors with access to investments in late-stage private companies.

Upfront, Claremont, Huntington lead late-decade venture portfolio at CalPERS

Urban Remedy fetches $17 mln Series B

Point Richmond, California-based Urban Remedy, a provider of organic, non-GMO and fresh food products, has secured $17 million in Series B funding. The lead investor was 301 INC. In addition to the funding, John Foraker will join Urban Remedy's board of directors.

Maverick Ventures rakes in over $130 mln for fund

Maverick Ventures has raised over $130 million for its debut fund, according to an SEC filing. The early-stage venture firm invests in the healthcare and tech sectors.

Kickstart Seed Fund wraps up fourth fund at $74 mln

Utah-based Kickstart Seed Fund has closed its fourth fund at $74 million. K4 will focus on making seed and early-stage investments in startups and entrepreneurs based in the Mountain West.

Despite the increased liquidity, blockchain venture investors hold tokens for the long-term